Toggle Nav
Close
  • Menu
  • Setting

GSK J4 free base

Catalog No.
B5959
histone demethylase JMJD3/UTX inhibitor
Grouped product items
SizePriceStock Qty
10mg
$95.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

GSK J4 free base (CAS 1373423-53-0) is a small-molecule inhibitor targeting the histone demethylases JMJD3/KDM6B and UTX/KDM6A. It functions by preventing the demethylation of histone H3 lysine 27 (H3K27me3/me2), resulting in epigenetic modulation. In vitro assays demonstrate that GSK J4 inhibits JMJD3/KDM6B and UTX/KDM6A with micromolar potency. In cellular studies, it suppresses inflammatory responses, notably reducing TNF-α secretion in LPS-stimulated human primary macrophages, and induces apoptosis associated with endoplasmic reticulum stress. GSK J4 is commonly employed in epigenetic and inflammation-related disease research.

Chemical Properties

Physical AppearanceWhite solid
StorageStore at -20°C
M.Wt417.46
Cas No.1373423-53-0
FormulaC24H27N5O2
Solubilityinsoluble in H2O; ≥20.5 mg/mL in EtOH; ≥27.75 mg/mL in DMSO
Chemical Nameethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate
SDFDownload SDF
Canonical SMILESCCOC(CCNC1=CC(N2CCC3=CC=CC=C3CC2)=NC(C4=CC=CC=N4)=N1)=O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control